Masaru Matsuda
Conseiller Juridique Général chez ARCUTIS BIOTHERAPEUTICS, INC.
Fortune : 2 M $ au 30/04/2024
Provenance du réseau au premier degré de Masaru Matsuda
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 32 | |
| Public Company | Biotechnology | 21 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Masaru Matsuda via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Administrative Officer Comptroller/Controller/Auditor Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| INTERMUNE INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer General Counsel | |
| KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Founder Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer | |
| VISTERRA INC | Pharmaceuticals: Major | Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Director of Finance/CFO | |
| CAREFUSION CORPORATION | Medical Distributors | Investor Relations Contact Human Resources Officer | |
Thesan Pharmaceuticals, Inc.
 Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| TURG POIN | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Stanford University | College/University | Masters Business Admin Doctorate Degree | |
| MEI PHARMA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| MIRATI THERAPEUTICS | Biotechnology | Human Resources Officer Director of Finance/CFO Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Undergraduate Degree Masters Business Admin | |
| Brooklyn College | College/University | Undergraduate Degree | |
| The Johns Hopkins University | College/University | Undergraduate Degree | |
| Pace University | College/University | Masters Business Admin | |
| University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
| ENDOCYTE, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| VAXCYTE, INC. | Biotechnology | Director/Board Member Director/Board Member Director of Finance/CFO | |
| SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director of Finance/CFO Director/Board Member | |
| KITE PHARMA INC | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Sales & Marketing | |
Amgen Europe BV
 Amgen Europe BV Medical DistributorsDistribution Services Part of Amgen, Inc., Amgen Europe BV wholesales pharmaceutical products. The company is based in Breda, Netherlands. | Medical Distributors | Corporate Officer/Principal Director of Finance/CFO | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Compliance Officer Corporate Officer/Principal | |
| ANACOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Compliance Officer | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Chairman Director of Finance/CFO | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Dompe Biotec SpA
 Dompe Biotec SpA Pharmaceuticals: MajorHealth Technology Dompe Biotec SpA (Dompé Biotec SpA) provides biotechnological drugs. Its products are used for the treatment of haematology, infectious diseases, nephrology, oncology, transfusion units and neuro-oncology. The company was founded in 1988 and is headquartered in Milan, Italy | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| VERRICA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ALLERGAN PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| SYNEOS HEALTH, INC. | Biotechnology | Director/Board Member | |
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member | |
Shire, Inc.
 Shire, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire, Inc. develops and markets medicines for patients with rare diseases. The company is based in Lexington, KY. | Pharmaceuticals: Major | Public Communications Contact | |
Renagade Therapeutics, Inc.
 Renagade Therapeutics, Inc. BiotechnologyHealth Technology Renagade Therapeutics, Inc. is an American US-based company that aims to overcome the limitations of RNA medicines by applying their comprehensive deliver, code, edit, insert technologies to precisely correct disease on an unprecedented scale. The company has developed a broad portfolio of RNA delivery systems, which profoundly expand the array of addressable diseases. The company's proprietary, synergistic toolkit allows them to precisely deliver, code, edit, and insert RNA medicines to treat any disease, anywhere in the body. Renagade is built on a foundation of proprietary delivery technologies to unlock previously inaccessible cells, reprogramming cells with superior expression using the leading RNA coding platform via joint venture with Orna Therapeutics, enabling curative therapies by permanently correcting defective genes with proprietary technology, and industry-leading all-RNA system to enable exon or large gene insertions as a gene therapy 2.0 platform. Renagade is backed by MPM BioImpact and F2 Ventures, leading financial groups who have supported the development of over 50 products to market. | Biotechnology | Director of Finance/CFO |
Statistiques
Internationale
| Etats-Unis | 42 |
| Royaume-Uni | 3 |
| Irlande | 3 |
| Suisse | 2 |
| Danemark | 2 |
Sectorielle
| Health Technology | 36 |
| Consumer Services | 10 |
| Distribution Services | 3 |
| Commercial Services | 3 |
| Finance | 2 |
Opérationnelle
| Director/Board Member | 131 |
| Corporate Officer/Principal | 99 |
| Independent Dir/Board Member | 57 |
| Undergraduate Degree | 44 |
| Chief Tech/Sci/R&D Officer | 28 |
Relations les plus connectées
| Insiders | |
|---|---|
| Patrick Heron | 42 |
| Joseph Turner | 22 |
| Keith Leonard | 20 |
| John Smither | 20 |
| Kenneth Kelley | 19 |
| Halley Gilbert | 17 |
| Bhaskar Chaudhuri | 16 |
| Laurie Stelzer | 13 |
| Howard Welgus | 12 |
| Harry Leonhardt | 12 |
| Michael E. Paolucci | 10 |
| Terrie Curran | 10 |
| Elaine Sun | 10 |
| Bernadette Connaughton | 10 |
| Albert Kildani | 9 |
- Bourse
- Insiders
- Masaru Matsuda
- Connexions Sociétés
